Tlr7-biallelism defines a hyperfunctional state of female B lymphocytes

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Bi-allelic Tlr7 expression in female B cells creates a hyperfunctional subset poised for antibody secretion, contributing to systemic autoimmunity and lupus development in mice.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

This preprint studied how escape of TLR7 from X-chromosome inactivation shapes female B-cell function, using female Tlr7-reporter mice to identify a mature B-cell subset with bi-allelic Tlr7 expression (BiA7). The BiA7 cells showed higher TLR7 protein, an epigenomic profile resembling memory B cells, independence from BCR self-reactivity or MyD88 signaling for development, and a requirement for boosting by type I interferon, with BiA7 cells accumulating in age-associated atypical memory B populations that drive systemic autoimmunity; constitutive ablation of these cells protected mice from lupus development. A stated caveat is that the work is presented as a preprint and not peer reviewed. This paper is centrally about endometriosis-adjacent female autoimmunity mechanisms — it focuses on TLR7/X-inactivation–driven hyperfunctional B cells and lupus rather than explicitly studying endometriosis or adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Enhanced dosage of the Toll-like receptor TLR7 is closely associated with sex disparities in systemic autoimmunity1-3. Remarkably, TLR7 escapes X chromosome inactivation in immune cells of women, leading to elevated protein levels4,5. However, the direct contribution of this process to immune cell function and systemic autoimmunity is unknown. Here, we use novel female Tlr7-reporter mice and identify a unique subset of mature B cells with bi-allelic Tlr7 expression (BiA7), with higher levels of TLR7 protein, poised for immediate differentiation into antibody secreting cells. We show that the epigenomic signature of BiA7 B cells resembles that of memory B cells, and that their development is independent of BCR self-reactivity or MyD88-signaling but is considerably boosted by type I IFN. Such BiA7 B cells accumulate in age-associated atypical memory B cell populations, which contribute to systemic autoimmunity. Accordingly, constitutive ablation of these cells protects mice from lupus development. Thus, Tlr7 expression from the inactive X chromosome characterizes a unique female-specific hyperactive subset of B lymphocytes and underlies systemic autoimmunity. Collectively, this study provides a mechanism to explain the X-linked genetic disparity in B cell immunity and supports future efforts to target X chromosome inactivation maintenance as a broad therapeutic strategy in sex-biased autoimmune disorders.
Full text 17,885 characters · extracted from preprint-html · click to expand
Tlr7-biallelism defines a hyperfunctional state of female B lymphocytes | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Biological Sciences - Article Tlr7-biallelism defines a hyperfunctional state of female B lymphocytes Jean Charles Guery, Charles-Henry Miquel, Mélissa Nieucel, Léa Ferrayé, and 13 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8306714/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Enhanced dosage of the Toll-like receptor TLR7 is closely associated with sex disparities in systemic autoimmunity1-3. Remarkably, TLR7 escapes X chromosome inactivation in immune cells of women, leading to elevated protein levels4,5. However, the direct contribution of this process to immune cell function and systemic autoimmunity is unknown. Here, we use novel female Tlr7-reporter mice and identify a unique subset of mature B cells with bi-allelic Tlr7 expression (BiA7), with higher levels of TLR7 protein, poised for immediate differentiation into antibody secreting cells. We show that the epigenomic signature of BiA7 B cells resembles that of memory B cells, and that their development is independent of BCR self-reactivity or MyD88-signaling but is considerably boosted by type I IFN. Such BiA7 B cells accumulate in age-associated atypical memory B cell populations, which contribute to systemic autoimmunity. Accordingly, constitutive ablation of these cells protects mice from lupus development. Thus, Tlr7 expression from the inactive X chromosome characterizes a unique female-specific hyperactive subset of B lymphocytes and underlies systemic autoimmunity. Collectively, this study provides a mechanism to explain the X-linked genetic disparity in B cell immunity and supports future efforts to target X chromosome inactivation maintenance as a broad therapeutic strategy in sex-biased autoimmune disorders. Biological sciences/Immunology/Autoimmunity Health sciences/Pathogenesis/Immunopathogenesis/Adaptive immunity/Humoral immunity Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryTable4.pdf Supplementary Table 4 supplementarytable2DAR.xlsx Supplementary Table 2 supplementarytable3RNAseqactivatedBcells.xlsx Supplementary Table 3 SupplementaryTable1BiAvsMonoA.FC1.padj0.05.xlsx Supplementary Table 1 ExtendedDataFigure110.pdf Extended Data Figure 1 to Figure 10 Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8306714","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Biological Sciences - Article","associatedPublications":[],"authors":[{"id":557217181,"identity":"bf2fcdc9-53f1-44cf-9a89-8afee5056bad","order_by":0,"name":"Jean Charles Guery","email":"data:image/png;base64,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","orcid":"https://orcid.org/0000-0003-4499-3270","institution":"INSERM","correspondingAuthor":true,"prefix":"","firstName":"Jean","middleName":"Charles","lastName":"Guery","suffix":""},{"id":557217182,"identity":"6a3f20ce-2c81-4ad0-8941-9fc332028993","order_by":1,"name":"Charles-Henry Miquel","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Charles-Henry","middleName":"","lastName":"Miquel","suffix":""},{"id":557217183,"identity":"04c46410-d588-4718-ba85-2baa03e0d821","order_by":2,"name":"Mélissa Nieucel","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Mélissa","middleName":"","lastName":"Nieucel","suffix":""},{"id":557217184,"identity":"9d129378-c3d3-4d3d-b6ea-7fca8c14822a","order_by":3,"name":"Léa Ferrayé","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Léa","middleName":"","lastName":"Ferrayé","suffix":""},{"id":557217185,"identity":"f368bb63-417e-4ee4-a9a1-8e8e95981c8a","order_by":4,"name":"Remi-Xavier Coux","email":"","orcid":"https://orcid.org/0000-0002-6114-2585","institution":"Institut Pasteur","correspondingAuthor":false,"prefix":"","firstName":"Remi-Xavier","middleName":"","lastName":"Coux","suffix":""},{"id":557217186,"identity":"81166294-9d5e-4f7e-b91b-86bb9a40cb48","order_by":5,"name":"Anne-Laure Iscache","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Anne-Laure","middleName":"","lastName":"Iscache","suffix":""},{"id":557217187,"identity":"172c4725-c9b0-4cce-b3c8-46ae4c4e9cd0","order_by":6,"name":"Claire Cenac","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Claire","middleName":"","lastName":"Cenac","suffix":""},{"id":557217188,"identity":"e232bf4d-31ea-4c5d-a3a1-3df184cb60d8","order_by":7,"name":"Berenice Faz-Lopez","email":"","orcid":"https://orcid.org/0000-0002-1160-8543","institution":"INSERM, Infinity - Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Berenice","middleName":"","lastName":"Faz-Lopez","suffix":""},{"id":557217189,"identity":"5b1caec9-726f-4682-b647-03449d7f83dc","order_by":8,"name":"Yann Aubert","email":"","orcid":"https://orcid.org/0000-0002-9769-6133","institution":"Capell Lab - University of Pennsylvania - Perelman School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Yann","middleName":"","lastName":"Aubert","suffix":""},{"id":557217190,"identity":"865cba07-4b52-402e-ad35-2cc2e7be301e","order_by":9,"name":"Hugo Garnier","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Hugo","middleName":"","lastName":"Garnier","suffix":""},{"id":557217191,"identity":"1b083621-1085-4ef8-bc2a-f787950924d2","order_by":10,"name":"Marie-Christine BIRLING","email":"","orcid":"https://orcid.org/0000-0002-3372-8108","institution":"IGBMC","correspondingAuthor":false,"prefix":"","firstName":"Marie-Christine","middleName":"","lastName":"BIRLING","suffix":""},{"id":557217192,"identity":"bf3c5b0b-ca93-4af5-aa7d-2726c9a1d2c9","order_by":11,"name":"Maxime Dubois","email":"","orcid":"","institution":"CNRS, Immunoconcept, Bordeaux University,","correspondingAuthor":false,"prefix":"","firstName":"Maxime","middleName":"","lastName":"Dubois","suffix":""},{"id":557217193,"identity":"c31a5f37-0791-400c-87b5-a3db3e7d1e80","order_by":12,"name":"Vanja Sisirak","email":"","orcid":"","institution":"CNRS, Immunoconcept, Bordeaux University,","correspondingAuthor":false,"prefix":"","firstName":"Vanja","middleName":"","lastName":"Sisirak","suffix":""},{"id":557217194,"identity":"de41a9c8-b950-484f-9ffb-8d45e5e9ab71","order_by":13,"name":"Zhaolin Hua","email":"","orcid":"","institution":"Institute of Biophysics, CAS","correspondingAuthor":false,"prefix":"","firstName":"Zhaolin","middleName":"","lastName":"Hua","suffix":""},{"id":557217195,"identity":"00a00058-671f-41ef-97d2-02fd4ba9f2d4","order_by":14,"name":"Baidong Hou","email":"","orcid":"https://orcid.org/0000-0002-0892-0181","institution":"Chinese Academy of Sciences","correspondingAuthor":false,"prefix":"","firstName":"Baidong","middleName":"","lastName":"Hou","suffix":""},{"id":557217196,"identity":"5c591873-7328-4582-9e9f-93fb5aba9b10","order_by":15,"name":"Magali Savignac","email":"","orcid":"","institution":"INSERM, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases","correspondingAuthor":false,"prefix":"","firstName":"Magali","middleName":"","lastName":"Savignac","suffix":""},{"id":557217197,"identity":"57ae6a47-27f9-4253-aa15-40152a2aa013","order_by":16,"name":"Julie Chaumeil","email":"","orcid":"https://orcid.org/0000-0002-8976-2890","institution":"Institut Cochin / INSERM","correspondingAuthor":false,"prefix":"","firstName":"Julie","middleName":"","lastName":"Chaumeil","suffix":""}],"badges":[],"createdAt":"2025-12-08 10:51:23","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8306714/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8306714/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":98431289,"identity":"a9e4e455-8295-4ccf-b78d-d11963a5b250","added_by":"auto","created_at":"2025-12-17 16:47:28","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2341445,"visible":true,"origin":"","legend":"Article File","description":"","filename":"Miqueletal.ALLcombinedXFigures15.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8306714/v1_covered_87f53433-bd1d-4724-b2ea-f5c8af68b31d.pdf"},{"id":97838606,"identity":"98515025-a5b2-4869-b359-ac06f4e765fb","added_by":"auto","created_at":"2025-12-10 03:04:06","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":92596,"visible":true,"origin":"","legend":"Supplementary Table 4","description":"","filename":"SupplementaryTable4.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8306714/v1/48edebc55a8e73e1d6320967.pdf"},{"id":97838607,"identity":"2847d377-85d1-44f3-ab4c-28c1f90e9c2c","added_by":"auto","created_at":"2025-12-10 03:04:06","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":166472,"visible":true,"origin":"","legend":"Supplementary Table 2","description":"","filename":"supplementarytable2DAR.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-8306714/v1/72cf64576f6b459c8861c5e7.xlsx"},{"id":97838608,"identity":"70bb430d-e301-4c4e-bb85-7e5bb04f0e94","added_by":"auto","created_at":"2025-12-10 03:04:06","extension":"xlsx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":5666389,"visible":true,"origin":"","legend":"Supplementary Table 3","description":"","filename":"supplementarytable3RNAseqactivatedBcells.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-8306714/v1/8eda1f79d1ba53e0b32a88e2.xlsx"},{"id":97838610,"identity":"88f36ab5-4234-41e2-8c35-c2841d1dd29f","added_by":"auto","created_at":"2025-12-10 03:04:06","extension":"xlsx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":6659338,"visible":true,"origin":"","legend":"Supplementary Table 1","description":"","filename":"SupplementaryTable1BiAvsMonoA.FC1.padj0.05.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-8306714/v1/c65cba9335e756bbceb5536b.xlsx"},{"id":97838609,"identity":"f89c8186-f472-4bd9-adf2-6905fce21de7","added_by":"auto","created_at":"2025-12-10 03:04:06","extension":"pdf","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":7439109,"visible":true,"origin":"","legend":"Extended Data Figure 1 to Figure 10","description":"","filename":"ExtendedDataFigure110.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8306714/v1/ded4e3efb8cf6e62df905e4e.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Tlr7-biallelism defines a hyperfunctional state of female B lymphocytes","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-8306714/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8306714/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Enhanced dosage of the Toll-like receptor TLR7 is closely associated with sex disparities in systemic autoimmunity1-3. Remarkably, TLR7 escapes X chromosome inactivation in immune cells of women, leading to elevated protein levels4,5. However, the direct contribution of this process to immune cell function and systemic autoimmunity is unknown. Here, we use novel female Tlr7-reporter mice and identify a unique subset of mature B cells with bi-allelic Tlr7 expression (BiA7), with higher levels of TLR7 protein, poised for immediate differentiation into antibody secreting cells. We show that the epigenomic signature of BiA7 B cells resembles that of memory B cells, and that their development is independent of BCR self-reactivity or MyD88-signaling but is considerably boosted by type I IFN. Such BiA7 B cells accumulate in age-associated atypical memory B cell populations, which contribute to systemic autoimmunity. Accordingly, constitutive ablation of these cells protects mice from lupus development. Thus, Tlr7 expression from the inactive X chromosome characterizes a unique female-specific hyperactive subset of B lymphocytes and underlies systemic autoimmunity. Collectively, this study provides a mechanism to explain the X-linked genetic disparity in B cell immunity and supports future efforts to target X chromosome inactivation maintenance as a broad therapeutic strategy in sex-biased autoimmune disorders.","manuscriptTitle":"Tlr7-biallelism defines a hyperfunctional state of female B lymphocytes","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-12-10 03:04:01","doi":"10.21203/rs.3.rs-8306714/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"e30ebe35-55f0-466f-8549-965bfd482198","owner":[],"postedDate":"December 10th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":59304846,"name":"Biological sciences/Immunology/Autoimmunity"},{"id":59304847,"name":"Health sciences/Pathogenesis/Immunopathogenesis/Adaptive immunity/Humoral immunity"}],"tags":[],"updatedAt":"2025-12-17T11:50:32+00:00","versionOfRecord":[],"versionCreatedAt":"2025-12-10 03:04:01","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8306714","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8306714","identity":"rs-8306714","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-27T02:00:06.600101+00:00
License: CC-BY-4.0